Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside (Q3225271)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside |
scientific article; zbMATH DE number 6015191
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside |
scientific article; zbMATH DE number 6015191 |
Statements
Hybrid Model of Erythropoiesis and Leukemia Treatment with Cytosine Arabinoside (English)
0 references
16 March 2012
0 references
chronotherapy
0 references
regulatory networks
0 references
cell cycle
0 references
0.7263973355293274
0 references
0.7240405678749084
0 references
0.6981626749038696
0 references
0.6964142918586731
0 references
